Profile data is unavailable for this security.
About the company
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1519 is used for the treatment of non-small cell lung cancer. ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. The Company develops drugs and medical devices derived from plants.
- Revenue in USD (TTM)152.43k
- Net income in USD-10.52m
- Incorporated2002
- Employees16.00
- LocationABVC Biopharma Inc44370 Old Warm Springs BlvdFREMONT 94538-6148United StatesUSA
- Phone+1 (510) 668-0881
- Websitehttps://abvcpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NanoString Technologies Inc | 162.47m | -166.43m | 12.37m | 703.00 | -- | -- | -- | 0.0761 | -3.53 | -3.53 | 3.44 | -1.05 | 0.4936 | 2.07 | 4.30 | 231,113.80 | -50.56 | -30.01 | -62.82 | -34.66 | 35.72 | 57.14 | -102.44 | -80.87 | 2.02 | -70.17 | 1.29 | -- | -12.28 | 2.06 | -38.43 | -- | 40.03 | -- |
| Mira Pharmaceuticals Inc | 0.00 | -11.98m | 12.56m | 3.00 | -- | 2.87 | -- | -- | -0.8314 | -0.8314 | 0.00 | 0.296 | 0.00 | -- | -- | 0.00 | -413.86 | -- | -620.46 | -- | -- | -- | -- | -- | -- | -2.47 | 0.00 | -- | -- | -- | -69.77 | -- | -- | -- |
| America Great Health | 219.13k | -859.20k | 12.67m | 7.00 | -- | -- | -- | 57.81 | -0.00004 | -0.00004 | 0.00001 | -0.0002 | 0.6746 | 0.0721 | 18.16 | 31,304.29 | -265.62 | -543.96 | -- | -- | 95.92 | -247.36 | -393.74 | -1,193.55 | 0.035 | -1.37 | -- | -- | 95.23 | -- | 84.35 | -- | -- | -- |
| Check Cap Ltd | 0.00 | -17.62m | 13.01m | 85.00 | -- | 0.4751 | -- | -- | -3.01 | -3.01 | 0.00 | 4.68 | 0.00 | -- | -- | 0.00 | -44.86 | -58.80 | -48.21 | -66.41 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.08 | -- | 16.04 | -- |
| China Health Industries Holdings, Inc. | 117.28k | -1.51m | 13.11m | 32.00 | -- | -- | -- | 111.77 | -0.023 | -0.023 | 0.0018 | -0.0349 | 0.0044 | 0.5692 | 25.25 | 3,665.00 | -5.72 | 3.04 | -7.60 | 3.66 | -2.37 | 69.55 | -1,287.13 | 28.61 | 0.0377 | -- | 1.68 | -- | 41,225.93 | -55.72 | -15.49 | -- | -- | -- |
| Medical Marijuana Inc | -100.00bn | -100.00bn | 13.19m | -- | -- | 0.142 | -- | -- | -- | -- | -- | 0.019 | -- | -- | -- | -- | -- | -22.66 | -- | -23.11 | -- | 70.58 | -- | -145.52 | 1.79 | -- | 0.0479 | -- | 26.30 | 39.07 | 141.59 | -- | -0.016 | -- |
| Kiora Pharmaceuticals Inc | 0.00 | -13.04m | 13.20m | 12.00 | -- | 0.6339 | -- | -- | -2.98 | -2.98 | 0.00 | 0.7929 | 0.00 | -- | -- | 0.00 | -77.27 | -70.52 | -91.06 | -81.86 | -- | -- | -- | -2,040.61 | -- | -- | 0.00 | -- | -- | -- | 3.97 | -- | -- | -- |
| ABVC Biopharma Inc | 152.43k | -10.52m | 13.20m | 16.00 | -- | 1.18 | -- | 86.60 | -2.52 | -2.52 | 0.0352 | 1.06 | 0.0127 | -- | 0.3514 | 9,526.88 | -90.65 | -103.38 | -171.60 | -231.54 | -98.15 | 76.25 | -7,157.57 | -2,019.89 | -- | -3.28 | 0.153 | -- | -84.28 | 85.39 | 35.97 | -- | -- | -- |
| Nexgel Inc | 4.09m | -3.16m | 13.20m | 19.00 | -- | 2.59 | -- | 3.23 | -0.5566 | -0.5566 | 0.7212 | 0.818 | 0.4027 | 3.81 | 9.57 | 215,263.20 | -31.39 | -44.61 | -38.80 | -56.19 | 15.16 | 5.02 | -77.95 | -180.98 | 1.46 | -- | 0.1396 | -- | 99.66 | 13.06 | 33.48 | -- | -- | -- |
| Microbot Medical Inc | 0.00 | -10.74m | 13.28m | 22.00 | -- | 2.40 | -- | -- | -1.08 | -1.08 | 0.00 | 0.3845 | 0.00 | -- | -- | 0.00 | -120.24 | -53.28 | -178.87 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
| Actavia Life Sciences Inc | 0.00 | -4.44m | 13.35m | 1.00 | -- | -- | -- | -- | -0.0074 | -0.0074 | 0.00 | -0.0027 | 0.00 | -- | -- | 0.00 | -10,235.89 | -158.17 | -- | -- | -- | -- | -- | -- | -- | -21.20 | -- | -- | -- | -- | -547.04 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 13.47m | 233.00 | 0.0904 | 0.0014 | 3.49 | 0.1903 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Trinity Biotech plc (ADR) | 56.83m | -36.87m | 13.91m | 398.00 | -- | -- | -- | 0.2447 | -17.71 | -9.31 | 12.36 | -15.67 | 0.7501 | 1.76 | 3.83 | -- | -48.66 | -19.82 | -61.89 | -28.84 | 34.22 | 39.90 | -64.88 | -28.30 | 1.27 | -1.61 | 1.77 | -- | -9.10 | -10.15 | 15.41 | -- | -31.08 | -- |
Data as of May 01 2024. Currency figures normalised to ABVC Biopharma Inc's reporting currency: US Dollar USD
1.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 31 Dec 2023 | 36.10k | 0.34% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 27.25k | 0.26% |
| Citadel Securities LLCas of 31 Dec 2023 | 27.16k | 0.26% |
| Geode Capital Management LLCas of 31 Dec 2023 | 19.48k | 0.18% |
| Tower Research Capital LLCas of 31 Dec 2023 | 578.00 | 0.01% |
| Spotlight Asset Group, Inc.as of 31 Dec 2023 | 100.00 | 0.00% |
| RBC Dominion Securities, Inc.as of 31 Dec 2023 | 37.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Dec 2023 | 20.00 | 0.00% |
| Virtu Americas LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
